Erratum: Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
Mol Clin Oncol
.
2020 Dec;13(6):78.
doi: 10.3892/mco.2020.2148.
Epub 2020 Sep 25.
Authors
Yasuyoshi Miyata
,
Kyohei Araki
,
Kojiro Ohba
,
Tomhiro Mastuo
,
Yuichiro Nakamura
,
Tsutomu Yuno
,
Yuta Mukai
,
Asato Otsubo
,
Kensuke Mitsunari
,
Yasushi Mochizuki
,
Hideki Sakai
PMID:
33062268
PMCID:
PMC7549394
DOI:
10.3892/mco.2020.2148
Abstract
[This corrects the article DOI: 10.3892/mco.2020.2099.].
Copyright: © Miyata et al.
Publication types
Published Erratum